R.H. Bluestein & Co’s SkinHealth Systems SKIN Stock Holding History

R.H. Bluestein & Co’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-750	Closed	-$390K	–	421
2021 Q3	$390K	Buy	+750	New	+$330K	0.02%	258

Other funds holding SKIN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

LCG

Luxor Capital Group New York $2.52B AUM 29.31% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

R.H. Bluestein & Co's SKIN Position: Q4 2021 in Review

R.H. Bluestein & Co sold out of SkinHealth Systems (SKIN) in Q4 2021, closing a stake of 750 shares — an estimated $390K sold.

R.H. Bluestein & Co first reported a position in SKIN in Q3 2021 and held it in 1 quarter. The position peaked at $390K in Q3 2021. 165 funds tracked by Wall St. Rank hold SKIN as of Q4 2021.

R.H. Bluestein & Co reported no remaining SkinHealth Systems position as of Q4 2021 after selling out during the quarter.
R.H. Bluestein & Co sold 750 SkinHealth Systems shares in Q4 2021, an estimated $390K.
R.H. Bluestein & Co first reported a position in SkinHealth Systems in Q3 2021 and held it in 1 quarter.
R.H. Bluestein & Co's SkinHealth Systems position peaked at $390K in Q3 2021.
165 funds tracked by Wall St. Rank held SkinHealth Systems as of Q4 2021.

Based on R.H. Bluestein & Co's 13F filing for Q4 2021, filed 14 Feb 2022.